Peter Lim to inject healthcare assets into Rowsley

Singapore

REAL estate and investment firm Rowsley said on Tuesday night that controlling shareholder, Singapore billionaire Peter Lim, will be injecting his 100 per cent stake in Thomson Medical Pte Ltd and 70.36 per cent stake in Bursa Malaysia-listed TMC Life Sciences (TMCLS) into the firm.

The proposed acquisitions are valued at up to S$1.9 billion, and will be financed through up to 25.3 billion consideration shares issued by Rowsley to Mr Lim at S$0.075 a share.

Rowsley chairman Ng Ser Miang said in a statement: "Healthcare is a big and growing market due to aging demographics, longer lifespans, major trends to increase birt…